Grande, Giulia
Vetrano, Davide L.
Marconi, Ettore
Bianchini, Elisa
Cricelli, Iacopo
Lovato, Valeria
Guglielmini, Luisa
Taddeo, Daiana
Cappa, Stefano F.
Cricelli, Claudio
Lapi, Francesco http://orcid.org/0000-0002-4342-9128
Article History
Received: 7 March 2022
Accepted: 5 July 2022
First Online: 18 July 2022
Declarations
:
: According to a by-law on the classification and implementation of observational drug-related research, as issued by the Italian Medicines Agency, the present study does not require approval by an ethics committee.
: FL, EM, EB and IC provided consultancies in protocol preparation for epidemiological studies and data analyses for Roche and Abbvie; DT and CC provided clinical consultancies for Roche, Abbvie and Viatris; VL and LG are employees of Roche S.p.A., Monza, Italy; the other co-authors have no conflict of interest to diclose.